功能化学品
Search documents
联化科技跌2.03%,成交额2.68亿元,主力资金净流出1465.76万元
Xin Lang Cai Jing· 2025-11-24 02:38
11月24日,联化科技盘中下跌2.03%,截至10:21,报11.60元/股,成交2.68亿元,换手率2.53%,总市值 104.39亿元。 资金流向方面,主力资金净流出1465.76万元,特大单买入964.10万元,占比3.60%,卖出1359.26万元, 占比5.08%;大单买入4892.63万元,占比18.27%,卖出5963.23万元,占比22.27%。 联化科技今年以来股价涨111.29%,近5个交易日跌22.67%,近20日跌4.29%,近60日涨9.43%。 今年以来联化科技已经10次登上龙虎榜,最近一次登上龙虎榜为11月14日,当日龙虎榜净买入1.24亿 元;买入总计3.49亿元 ,占总成交额比15.86%;卖出总计2.26亿元 ,占总成交额比10.24%。 资料显示,联化科技股份有限公司位于浙江省台州市黄岩区劳动北路总商会大厦17楼,成立日期1998年 9月14日,上市日期2008年6月19日,公司主营业务涉及主营工业业务分为农药、医药和功能化学品三大 板块。农药板块主要从事农药原料药及中间体的生产、销售以及为国际农药企业提供定制生产、研发及 技术服务;医药板块主要从事原料药、中间体的生产、 ...
泰禾股份:11月20日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-11-21 04:01
Group 1 - The core point of the article is that Taihe Co., Ltd. announced the convening of its fourth board meeting on November 20, 2025, to discuss the proposal for the third extraordinary shareholders' meeting in 2025 [1] - For the year 2024, the revenue composition of Taihe Co., Ltd. is as follows: pesticides account for 85.02%, functional chemicals account for 11.2%, and others account for 3.78% [1]
泰禾股份:接受景顺长城基金调研
Mei Ri Jing Ji Xin Wen· 2025-11-19 11:53
Group 1 - The core viewpoint of the article is that Taihe Co., Ltd. (SZ 301665) has announced its participation in a research meeting with Invesco Great Wall Fund, where company executives addressed investor inquiries [1] - For the fiscal year 2024, Taihe Co., Ltd.'s revenue composition is as follows: pesticides account for 85.02%, functional chemicals for 11.2%, and others for 3.78% [1] - As of the report, Taihe Co., Ltd. has a market capitalization of 14 billion yuan [1]
泰禾股份11月17日获融资买入1835.27万元,融资余额8504.12万元
Xin Lang Cai Jing· 2025-11-18 01:47
资料显示,南通泰禾化工股份有限公司位于上海市长宁区临虹路365号北5座,成立日期2004年4月29 日,上市日期2025年4月11日,公司主营业务涉及农药产品以及功能化学品的研发、生产和销售。主营 业务收入构成为:除草剂43.14%,杀菌剂37.30%,功能化学品9.98%,其他9.57%。 截至11月10日,泰禾股份股东户数1.28万,较上期增加3.62%;人均流通股2989股,较上期减少3.49%。 2025年1月-9月,泰禾股份实现营业收入38.90亿元;归母净利润3.67亿元,同比增长120.56%。 11月17日,泰禾股份涨1.34%,成交额2.12亿元。两融数据显示,当日泰禾股份获融资买入额1835.27万 元,融资偿还2650.61万元,融资净买入-815.34万元。截至11月17日,泰禾股份融资融券余额合计 8504.12万元。 融资方面,泰禾股份当日融资买入1835.27万元。当前融资余额8504.12万元,占流通市值的6.99%。 融券方面,泰禾股份11月17日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00 元;融券余量0.00股,融券余额0.00元。 分红方面 ...
泰禾股份11月12日获融资买入813.06万元,融资余额8512.23万元
Xin Lang Cai Jing· 2025-11-13 01:45
Core Points - On November 12, Taihe Co., Ltd. experienced a decline of 1.65% in stock price, with a trading volume of 91.42 million yuan [1] - The financing data for Taihe on the same day showed a financing purchase amount of 8.13 million yuan and a financing repayment of 8.92 million yuan, resulting in a net financing outflow of 0.79 million yuan [1] - As of November 12, the total margin balance for Taihe was 85.12 million yuan, accounting for 7.20% of its market capitalization [1] Financing and Margin Data - The financing purchase on November 12 was 8.13 million yuan, while the current financing balance stands at 85.12 million yuan [1] - No shares were sold or repaid in the securities lending segment on November 12, with a total of 0 shares and 0 yuan in margin balance [1] Company Overview - Taihe Co., Ltd. is located in Changning District, Shanghai, and was established on April 29, 2004, with its listing date set for April 11, 2025 [1] - The company specializes in the research, production, and sales of pesticide products and functional chemicals, with revenue composition as follows: herbicides 43.14%, fungicides 37.30%, functional chemicals 9.98%, and others 9.57% [1] Financial Performance - For the period from January to September 2025, Taihe reported a revenue of 3.89 billion yuan and a net profit attributable to shareholders of 367 million yuan, reflecting a year-on-year growth of 120.56% [1] Shareholder Information - As of November 10, the number of shareholders for Taihe was 12,800, an increase of 3.62% from the previous period, with an average of 2,989 circulating shares per person, a decrease of 3.49% [1] - Since its A-share listing, Taihe has distributed a total of 270 million yuan in dividends [2] - As of September 30, 2025, Hong Kong Central Clearing Limited was the sixth largest circulating shareholder, holding 230,200 shares, a decrease of 171,700 shares from the previous period [2]
联化科技跌2.00%,成交额2.31亿元,主力资金净流出2930.56万元
Xin Lang Cai Jing· 2025-11-05 02:56
Core Viewpoint - Lianhua Technology's stock price has seen significant growth this year, with a year-to-date increase of 114.21%, despite a recent decline in trading activity [1] Group 1: Stock Performance - As of November 5, Lianhua Technology's stock price was 11.76 yuan per share, with a market capitalization of 10.717 billion yuan [1] - The stock experienced a net outflow of 29.31 million yuan in principal funds, with large orders showing a buy of 43.25 million yuan and a sell of 61.40 million yuan [1] - The stock has risen by 3.70% in the last five trading days, 7.30% in the last 20 days, and 9.40% in the last 60 days [1] Group 2: Company Overview - Lianhua Technology, established on September 14, 1998, and listed on June 19, 2008, operates in three main sectors: pesticides, pharmaceuticals, and functional chemicals [2] - The revenue composition is as follows: pesticides 54.03%, pharmaceuticals 32.32%, functional chemicals 8.42%, equipment and engineering services 4.88%, and others 0.36% [2] - The company is classified under the basic chemicals industry, specifically in pesticide products [2] Group 3: Financial Performance - For the period from January to September 2025, Lianhua Technology reported a revenue of 4.718 billion yuan, reflecting a year-on-year growth of 8.25% [2] - The net profit attributable to shareholders was 316 million yuan, showing a remarkable year-on-year increase of 871.65% [2] - The company has distributed a total of 960 million yuan in dividends since its A-share listing, with 129 million yuan distributed in the last three years [3]
联化科技股价涨5.15%,万家基金旗下1只基金重仓,持有2.08万股浮盈赚取1.25万元
Xin Lang Cai Jing· 2025-10-27 05:51
Group 1 - The core point of the article highlights the recent performance of Lianhua Technology, which saw a 5.15% increase in stock price, reaching 12.26 yuan per share, with a trading volume of 549 million yuan and a turnover rate of 5.07%, resulting in a total market capitalization of 11.173 billion yuan [1] - Lianhua Technology, established on September 14, 1998, and listed on June 19, 2008, operates in three main business segments: pesticides, pharmaceuticals, and functional chemicals. The revenue composition is as follows: plant protection 54.03%, pharmaceuticals 32.32%, functional chemicals 8.42%, equipment and engineering services 4.88%, and others 0.36% [1] Group 2 - From the perspective of fund holdings, only one fund under Wanjia Fund has Lianhua Technology as a major holding. The Wanjia CSI 2000 Index Enhanced A fund (019920) held 20,800 shares in the third quarter, accounting for 0.49% of the fund's net value, making it the largest holding. The estimated floating profit for today is approximately 12,500 yuan [2] - The Wanjia CSI 2000 Index Enhanced A fund is managed by Qiao Liang and Zhang Yongqiang. As of the report, Qiao Liang has a tenure of 6 years and 70 days, with a total asset scale of 5.886 billion yuan and a best fund return of 123.25% during his tenure. Zhang Yongqiang has a tenure of 2 years and 299 days, with a total asset scale of 1.806 billion yuan and a best fund return of 41.25% during his tenure [3]
联化科技涨2.01%,成交额2.51亿元,主力资金净流入2835.70万元
Xin Lang Cai Jing· 2025-10-24 05:37
Core Insights - Lianhua Technology's stock price increased by 2.01% on October 24, reaching 11.70 CNY per share, with a total market capitalization of 10.663 billion CNY [1] - The company has seen a significant stock price increase of 113.11% year-to-date, with recent trading performance showing a 1.92% increase over the last five days and a 7.64% increase over the last twenty days [1] Financial Performance - For the first half of 2025, Lianhua Technology reported a revenue of 3.15 billion CNY, representing a year-on-year growth of 5.76%, and a net profit attributable to shareholders of 224 million CNY, which is a remarkable increase of 1481.94% [2] - The company has distributed a total of 960 million CNY in dividends since its A-share listing, with 129 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased to 72,300, up by 88.92%, while the average circulating shares per person decreased by 47.07% to 12,533 shares [2] - Hong Kong Central Clearing Limited is the second-largest circulating shareholder, holding 40.3583 million shares, an increase of 21.3384 million shares from the previous period [3]
泰禾股份10月22日获融资买入353.42万元,融资余额8163.83万元
Xin Lang Cai Jing· 2025-10-23 01:48
Group 1 - The core viewpoint of the news highlights the recent trading performance and financial metrics of Taihe Co., indicating a slight increase in stock price and notable changes in financing activities [1][2] - As of October 22, Taihe Co. experienced a financing buy-in of 3.53 million yuan, with a net financing outflow of -1.13 million yuan, resulting in a total financing balance of 81.64 million yuan, which accounts for 7.65% of its market capitalization [1] - The company reported a revenue of 2.413 billion yuan for the first half of 2025, reflecting a year-on-year growth of 23.15%, and a net profit attributable to shareholders of 182 million yuan, marking a significant increase of 72.20% year-on-year [2] Group 2 - The company has distributed a total of 270 million yuan in dividends since its A-share listing [3] - As of June 30, 2025, the number of shareholders for Taihe Co. decreased by 22.36% to 12,900, while the average number of circulating shares per shareholder increased by 37.21% to 2,965 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited emerged as the second-largest shareholder, acquiring 401,900 shares as a new investor [3]
联化科技跌2.05%,成交额3.42亿元,主力资金净流出4704.24万元
Xin Lang Zheng Quan· 2025-10-16 06:11
Core Viewpoint - Lianhua Technology's stock price has seen significant fluctuations, with a year-to-date increase of 109.11%, indicating strong market interest and potential growth opportunities [1][2]. Financial Performance - For the first half of 2025, Lianhua Technology reported revenue of 3.15 billion yuan, a year-on-year increase of 5.76%, and a net profit attributable to shareholders of 224 million yuan, reflecting a substantial growth of 1481.94% [2]. - The company has distributed a total of 960 million yuan in dividends since its A-share listing, with 129 million yuan distributed over the past three years [3]. Stock Market Activity - As of October 16, Lianhua Technology's stock was trading at 11.48 yuan per share, with a market capitalization of 10.462 billion yuan. The stock experienced a net outflow of 47.04 million yuan in principal funds [1]. - The company has appeared on the stock market's "龙虎榜" (top trading list) nine times this year, with the most recent appearance on June 25, where it recorded a net buy of -46.85 million yuan [1]. Business Segments - Lianhua Technology operates in three main business segments: pesticides (54.03% of revenue), pharmaceuticals (32.32%), and functional chemicals (8.42%), with equipment and engineering services contributing 4.88% [2]. - The company provides customized production, research, and technical services for international pesticide and pharmaceutical companies [2]. Shareholder Structure - As of June 30, 2025, Lianhua Technology had 72,300 shareholders, an increase of 88.92% from the previous period, with an average of 12,533 circulating shares per shareholder, a decrease of 47.07% [2][3]. - Hong Kong Central Clearing Limited is the second-largest circulating shareholder, holding 40.3583 million shares, an increase of 21.3384 million shares from the previous period [3].